Parabolan 100 100mg/ml 10ml Vial by Dragon-Pharma

Usage

1. Confirm the cycle schedule before opening the vial: map injection days across the full planned 10–12 week run and calculate total volume needed from the 10ml vial.
2. Inspect the vial under light before the first draw — the oil solution should appear clear to pale yellow with no visible particulate matter; if cloudiness or precipitation is present, do not use.
3. Wipe the vial stopper with a 70% isopropyl alcohol swab and allow it to dry fully before each draw to maintain sterility across multiple uses over the cycle.
4. Draw the required volume using a 21G needle to ease aspiration of the oil vehicle, then swap to a fresh 23G or 25G needle for intramuscular injection (glute, vastus lateralis, or delt).
5. Rotate injection sites across the cycle to prevent local tissue fatigue — with twice-weekly dosing, a four-site rotation (left glute / right glute / left quad / right quad) distributes mechanical burden evenly.
6. Log each injection date and dose in a cycle diary: this creates an accurate timeline for calculating the post-last-injection clearance window and ensures PCT is initiated at the correct point relative to the final Parabolan 100 draw.

Warnings

Frequently asked questions

How do you incorporate Dragon-Pharma Parabolan 100 into a modern cycle structure?

Parabolan 100 is best positioned as a core compound running the full active phase of a modern 8–12 week cycle, typically from week 1 through week 10. Its twice-weekly injection schedule (e.g. Monday and Thursday) fits standard modern cycle calendars without creating the daily-injection burden associated with faster Trenbolone esters. Most practitioners pair it with a long-acting testosterone ester to maintain androgenic balance throughout.

When in the cycle should you start Parabolan 100 to optimise plasma build-up?

Starting Parabolan 100 on day 1 of the cycle allows plasma Trenbolone levels to build progressively during weeks 1 and 2, reaching a stable therapeutic range by week 3 — a timeline consistent with the compound's ester-governed absorption rate. Delaying the start to mid-cycle shortens the effective window without improving tolerability, making a week-1 start the standard approach in modern protocol design.

How long does a modern Trenbolone Hexahydrobenzylcarbonate cycle typically run?

Ten to twelve weeks is the typical modern cycle length for Trenbolone Hexahydrobenzylcarbonate. An 8-week minimum is required to progress through the compound's build-up phase and realise meaningful recomposition or strength outcomes. Extending beyond 12 weeks increases suppression depth without proportional benefit, so contemporary cycle templates cap active use at 10–12 weeks followed by a structured clearance window before PCT.

Can you draw Parabolan 100 with an insulin syringe for precise dosing?

Yes — the 100mg/ml concentration in sesame or cottonseed oil vehicle is viscous enough to require a wider-gauge drawing needle (21G recommended), but volumes of 1.0–1.5ml per injection site are manageable with standard 2ml syringes. Insulin syringes (0.5–1.0ml capacity) are suitable only for sub-1ml draws; for typical twice-weekly doses of 150mg (1.5ml), a standard 3ml luer-lock syringe with a 23G injection needle is more practical.

How should the Parabolan 100 vial be stored after first use?

After the first draw, store the vial in a cool, dark location between 15°C and 25°C — room temperature is acceptable provided it is stable. Refrigeration is not required and may increase oil viscosity, making draws more difficult. Avoid freezing. The rubber stopper should be wiped with a fresh alcohol swab before each subsequent draw. Within a 10–12 week cycle at twice-weekly dosing, the vial will typically be exhausted before storage duration becomes a degradation concern. (2) angle_used

Manufacturer

Batch-to-batch consistency in Dragon-Pharma's Parabolan 100 is enforced at three sequential production checkpoints rather than as a single end-of-line release test. First, the active pharmaceutical ingredient — Trenbolone Hexahydrobenzylcarbonate — is assayed for purity and identity by HPLC before it enters the compounding stage; only material meeting the internal specification proceeds to formulation. Second, the finished oil solution is sampled from the bulk mixing vessel and re-assayed to confirm that the blend has achieved the target 100mg/ml concentration within the accepted variance band — a step that catches formulation errors before any volume enters a vial. Third, filled and sealed vials from each batch undergo LAL endotoxin quantification and visual inspection for particulate contamination before a batch release decision is made. The result across Parabolan 100's production history is a concentration consistency that experienced users running multi-week cycles — drawing from the same vial across ten or more injection events — can verify: volume-adjusted dose remains predictable from first draw to last, a reproducibility characteristic that Dragon-Pharma's third-party audit records document at the batch level.